🇺🇸 FDA
Patent

US 9512107

Therapeutically active compositions and their methods of use

granted A61KA61K31/53A61K31/5377

Quick answer

US patent 9512107 (Therapeutically active compositions and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/53, A61K31/5377, A61P, A61P35/00